User:Mr. Ibrahem/Telmisartan/hydrochlorothiazide

Telmisartan/hydrochlorothiazide, sold under the names Micardis HCT among others, is a medication used to treat high blood pressure. It is a combination of telmisartan an angiotensin II receptor antagonist with hydrochlorothiazide a diuretic. It may be used if telmisartan by itself is not sufficient. It is taken by mouth.

Common side effects include dizziness, upper respiratory tract infections, nausea, diarrhea, and tiredness. Severe side effects may include kidney problems, electrolyte problems, and allergic reactions. Use during pregnancy may harm the baby. Telmisartan works by blocking the effects of angiotensin II while hydrochlorothiazide works by decreasing the kidneys' ability to retain water.

The combination was approved for medical use in the United States in 2000. The combination is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. A month of medication costs the NHS about £17 as of 2018. In the United States it costs about US$65 per month as of 2019.